Your human subject protocol may require additional reviews and approvals prior to the final IRB approval being issued. The Principal Investigator of the trial is responsible for ensuring the appropriate applications and submissions are obtained when initiating a trial. The information below will provide you access to additional information when implementing a new trial. The individuals responsible for each committee can provide you with the current information and answer questions you may have.
1.
Medical Radiation Sub Committee (MRC) - Evaluate all proposal for research, diagnostic, and therapeutic use of radioisotopes and radiation producing (ionizing and non-ionizing) devices anywhere within Temple University involving application or administration of radiation or radoactive materials to humans.
Approval from the committee is required for all research protocols involving radiation exposure to humans that is outside the practice of standard of care
Contact person is Kurt Bodison Assistant Director, Environmental Health & Radiation Safety Phone: 215-707-7646 Email: kurt.bodison@temple.edu.
Temple and Fox Chase IRB Protocols approvals - MRC approval maybe obtained at the same time as the IRB Submission
WIRB IRB Protocol approvals- MRC approval must be obtained prior to sending the protocol to WIRB
2.
Fox Chase Research Review Committee (RRC - Web Page)- Submission, Review and Approval must be obtained from the Fox Chase RRC prior to the IRB submission and review. The RRC web-site contains the most current information regarding the committee requirements and contact information.
Fox Chase IRB Application Instructions-
The submission guidelines for completing a proposal to the Fox Chase Research Review Committee. These guidelines provide current instructions and process for a new protoocl reveiw at FCCC.
Institutional BioSafety Committee - The Temple University Institutional Biosafety Committee (IBC) is responsible for the regulation and monitoring of all University research that involves recombinant DNA, infectious agents, and other biohazards.
Pharmacy And Therapeutics - If an Investigational Drug is used submit a copy of the IDDS form to the TUH Investigational Pharmacy. You can contact Investigational Drug Services Pharmacist Christine Fitzgerald at 215 707-9346.
